Skip to main content
Clinical Trials/NCT04040933
NCT04040933
Completed
Not Applicable

A 28-Day, Single-Center, Randomized, Comparator-Controlled, Proof-of-Principle Study to Assess Wound Healing Efficacies of Different Adhesive Bandages

Johnson & Johnson Consumer Inc. (J&JCI)1 site in 1 country36 target enrollmentAugust 9, 2019
ConditionsWound Healing

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Wound Healing
Sponsor
Johnson & Johnson Consumer Inc. (J&JCI)
Enrollment
36
Locations
1
Primary Endpoint
Time to Complete Wound Healing
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this study is to assess the wound healing efficacy (time to complete healing) of different adhesive bandages.

Registry
clinicaltrials.gov
Start Date
August 9, 2019
End Date
October 30, 2019
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Johnson & Johnson Consumer Inc. (J&JCI)
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Fitzpatrick Skin Type II or III
  • Uniform skin color on both volar forearms
  • Generally in good health based on medical history reported by the participant
  • -Individual has signed the Photographic Release and Informed Consent Documents along with (HIPAA) disclosure
  • Willing to have temporary (semi-permanent) dot-tattoos applied to the volar forearms

Exclusion Criteria

  • Has known allergies, hypersensitivity, or adverse reactions to anesthetics, adhesive bandages, latex, wound treatment products, or any component/ingredient present in the Investigational Products (IPs)/auxiliary/ancillary products
  • Has a known history of a blood-clotting disorder, keloid formation, or a cardiovascular, hepatic, or renal disease
  • Presents with a skin condition that would, in the opinion of the PI or Study Physician, confound study results, increase risk to participant, or interfere with study evaluations
  • Has excessive hair or tattoos on either volar forearm
  • Has a known history of severe systemic immune system disorders
  • Has self-reported Type 1 or Type 2 diabetes
  • Has self-reported uncontrolled chronic diseases
  • Is taking medication that would mask an adverse event, confound study results or alter/compromise the bleeding/healing process
  • Is self-reported to be pregnant or planning to become pregnant
  • Has a body mass index (BMI) above 35

Outcomes

Primary Outcomes

Time to Complete Wound Healing

Time Frame: Up to Day 16

Time to complete wound healing: time(in days) elapsed from time of wound creation to 12 PM of day (up to Day 16) on which composite healing score(CHS) first meets complete healing criterion of being at least a score of 8 (threshold for complete healing). CHS was calculated from clinical grading of wound healing parameters as general wound appearance (0 \[Poor-New or fresh wound with epithelium layer missing, wound bed appears raw and possibly oozing\] to 4 \[Excellent-Fully healed, skin flush against surrounding skin, slight color mismatch may be present\])+smoothness (0 \[Rough, uneven wound\]- 4 \[complete smoothness, even wound\])+epithelial confluence (0 \[None\]- 4 \[91-100%full epithelial growth\]) - erythema (0 \[None\]- 4 \[Severe\]) - edema (0 \[None\]- 4 \[Severe\]) - crusting/scabbing (0 \[None\]- 4 \[90-100% crusting/scabbing\]). CHS on 25-point scale (-12 \[no healing\] to +12 \[towards healing\]) is indicative of extent of wound healing and was calculated for each wound site at each evaluation day.

Secondary Outcomes

  • Change From Baseline in Clinical Grading of Wound Healing Parameter - Erythema(Day 0 (immediate after wound creation), Day 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 and 16)
  • Change From Baseline in Painful Score With Arm Resting by Side(Baseline, Day 1, 2, 3 and 4)
  • Change From Baseline in Trans-Epidermal Water Loss (TEWL) Measurements(Day 0 (immediate after wound creation), Day 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 and 14)
  • Change From Baseline in Clinical Grading of Wound Healing Parameter - Edema(Day 0 (immediate after wound creation), Day 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 and 16)
  • Change From Baseline in Composite Scar Score(Baseline and Day 28)
  • Change From Baseline in Itchy Score(Baseline, Day 1, 2, 3 and 4)
  • Change From Baseline in Painful Score With Arm in Normal Motion(Baseline, Day 1, 2, 3 and 4)
  • Number of Participants With Pain Duration With Arm Resting by Side(Day 1, 2, 3 and 4)
  • Number of Participants With Pain Duration With Arm in Normal Motion(Day 1, 2, 3 and 4)

Study Sites (1)

Loading locations...

Similar Trials